pharma · Dravet Syndrome · Dravet syndrome · STOK
Stoke Therapeutics
Stoke Therapeutics trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
Bedford, USA HQ
2017 Founded
205 Employees
Public company Type
STOK · NYSE Ticker
Company details
- Status
- Public
- HQ
- Bedford, USA
- Founded
- 2017
- Employees
- 205
- Programs
- 8
- Drugs
- 4
- Patents
- 14
Stoke Therapeutics clinical trials
Registry index of 8 ClinicalTrials.gov studies linked to Stoke Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Stoke Therapeutics trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Stoke Therapeutics.
-
Transanal irrigation with Peristeen Anal Irrigation — Approved
Clinical update -
STK-002 — Phase 1
Clinical update -
STK-001 - Single Ascending Doses — Phase 2
Clinical update -
STK-001, STK-001 — Phase 3
Clinical update -
zorevunersen — Phase 3
Clinical update -
Milrinone — Phase 2
Clinical update -
zorevunersen (STK-001) — Phase 2
Clinical update -
Pethidine — Approved
Clinical update